Moreover, compared to the CRC group, L‐tianma, M‐tianma, H‐tianma, or 5‐Fu treatments reduced TNF‐α, IL‐1β and IL‐6 levels, and increased IFN‐γ levels (Figure 2D–G). This evidence concerns the gene TNF and colorectal carcinoma.